Does the use of a uterine manipulator in robotic surgery for early‐stage endometrial cancer affect oncological outcomes?. Issue 6 (24th August 2022)

• Record Type: Journal Article
• Authors: Ito, Hiroe; Moritake, Tetsuya; Isaka, Keiichi
• Is Part Of: International journal of medical robotics and computer assisted surgery. Volume 18:Issue 6(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-08-24
• Subjects: endometrial cancer -- oncological outcome -- robotic surgery -- uterine manipulator; Robotics in medicine -- Periodicals; Surgery -- Technological innovations -- Periodicals; Imaging systems in medicine -- Periodicals; 617.90285
• DOI: 10.1002/rcs.2443
• Languages: English
• ISSNs: 1478-5951

Abstract

Abstract: Background: To investigate the impact of the use of a uterine manipulator in robot‐assisted surgery for early‐stage endometrial cancer on oncological outcome. Methods: Eighty six robotic surgeries and sixty seven open surgeries were performed for early‐stage endometrial cancer. Disease‐free survival and overall survival at 5 years, and surgical results and postoperative complications were compared between surgeries. In robotic surgery, a uterine manipulator was used in all cases. Results: There was no significant difference in oncological outcome between surgeries. Robotic surgery showed significantly longer operative time, less blood loss, and shorter hospital stay compared to open surgery. In robotic surgery, complications occurred significantly less frequently, and no patients required conversion to laparotomy. There were no clear correlations of positive lavage cytology with The International Federation of Gynecology nd Obstetrics stage, recurrence, and site of recurrence in either surgery. Conclusions: The use of a uterine manipulator during robotic surgery for early‐stage endometrial cancer did not influence recurrence or survival.